Axiom Therapeutics

Axiom Therapeutics is an early-stage startup founded by two PhDs from the University of Cambridge with backgrounds in Computational Chemistry and drug discovery. It aims to build a computational platform that helps pharmaceutical companies discover and develop new covalent drugs. This vision has the potential to transform the pharmaceutical industry. Axiom's approach can revolutionize the discovery process of new covalent drugs. Its breadth (millions of drugs against a few thousand used today) and speed could allow pharma partners to exceed what they can do in the wet lab today.
Axiom colour logo
Founders / Management Ryan Geiser, Chris Haggard
Sectors Frontiers in Health & Bio
Located in London, UK
Co-Investors Lunar Ventures
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.